Որոնման արդյունքները - Mathew Vithayathil
- Ցուցադրվում են 1 - 16 արդյունքները 16
-
1
Epidemiology of cholangiocarcinoma Maria Qurashi, Mathew Vithayathil, Shahid A. Khan
Հրապարակվել է 2023Revisão -
2
-
3
Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study Mathew Vithayathil, Paul Carter, Siddhartha Kar, Amy M. Mason, Stephen Burgess, Susanna C. Larsson
Հրապարակվել է 2021Artigo -
4
Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two‐sample Mendelian randomization study Shuai Yuan, Siddhartha Kar, Mathew Vithayathil, Paul Carter, Amy M. Mason, Stephen Burgess, Susanna C. Larsson
Հրապարակվել է 2020Revisão -
5
-
6
Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants Susanna C. Larsson, Paul Carter, Siddhartha Kar, Mathew Vithayathil, Amy M. Mason, Karl Michaëlsson, Stephen Burgess
Հրապարակվել է 2020Artigo -
7
-
8
-
9
-
10
-
11
Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma Mathew Vithayathil, Deniz Koku, Claudia Campani, Jean-Charles Nault, Olivier Sutter, Nathalie Ganne Carrié, Eric O. Aboagye, Rohini Sharma
Հրապարակվել է 2025Artigo -
12
-
13
Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study Shuai Yuan, Paul Carter, Maria Bruzelius, Mathew Vithayathil, Siddhartha Kar, Amy M. Mason, Ang Lin, Stephen Burgess, Susanna C. Larsson
Հրապարակվել է 2020Artigo -
14
-
15
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma
Հրապարակվել է 2022Artigo -
16
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma
Հրապարակվել է 2023Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Cancer
Oncology
Biology
Gene
Genetics
Genotype
Genetic variants
Mendelian randomization
Odds ratio
Confidence interval
Gastroenterology
Breast cancer
Chemotherapy
Hepatocellular carcinoma
Immunotherapy
Adverse effect
Atezolizumab
Bevacizumab
Bioinformatics
Clinical trial
Disease
Gynecology
Nivolumab
Biobank
Body mass index
Demography
Kidney cancer
Physiology